Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
Public ClinicalTrials.gov record NCT01511198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). The aim of this trial is to determine the dose-response relationship for body weight and five escalating doses of NNC 90-1170 (liraglutide) in subjects with type 2 diabetes previously treated with an oral hypoglycemic agent (OHA).
Study identification
- NCT ID
- NCT01511198
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 223 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2001 (Type not available)
- Primary completion
- Oct 2001 (Actual)
- Completion
- Oct 2001 (Actual)
- Last update posted
- Jan 26, 2017
2001
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Vestavia Hills | Alabama | 35209 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85719 | — |
| Novo Nordisk Investigational Site | Carlisle | Arkansas | 72024 | — |
| Novo Nordisk Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Novo Nordisk Investigational Site | Alhambra | California | 91801 | — |
| Novo Nordisk Investigational Site | Mission Viejo | California | 92691 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Trumbull | Connecticut | 06611 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32216 | — |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33156 | — |
| Novo Nordisk Investigational Site | Ocala | Florida | 34471 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Novo Nordisk Investigational Site | St. Petersburg | Florida | 33702 | — |
| Novo Nordisk Investigational Site | Titusville | Florida | 32796 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33401 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62711 | — |
| Novo Nordisk Investigational Site | Worcester | Massachusetts | 01605 | — |
| Novo Nordisk Investigational Site | Duluth | Minnesota | 55805 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63117 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63141 | — |
| Novo Nordisk Investigational Site | North Plainfield | New Jersey | 07060 | — |
| Novo Nordisk Investigational Site | Charlotte | North Carolina | 28277 | — |
| Novo Nordisk Investigational Site | Durham | North Carolina | 27710 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Novo Nordisk Investigational Site | Corpus Christi | Texas | 78404 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78209 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84132 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23294 | — |
| Novo Nordisk Investigational Site | Edmonds | Washington | 98026-7610 | — |
| Novo Nordisk Investigational Site | Edmonds | Washington | 98026 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
| Novo Nordisk Investigational Site | Tacoma | Washington | 98405 | — |
| Novo Nordisk Investigational Site | Charleston | West Virginia | 25301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01511198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01511198 live on ClinicalTrials.gov.